The vasopeptidase inhibitor AVE7688 ameliorates type 2 diabetic nephropathy. - Schafer,S.; Linz,W.; Vollert,H.; Biemer-Daub,G.; Rütten,H.; Bleich,M.; Busch,AE. (Diabetologia, 2004)